Preclinical testing of recombinant adenoviral herpes simplex virus- thymidine kinase gene therapy for central nervous system malignancies

1997-08-01

Neurosurgery , Volume 41 - Issue 2 p. 442- 452

Additional Metadata
Keywords	CNS tumors, Recombinant adenovirus, Suicide gene therapy
Persistent URL	doi.org/10.1097/00006123-199708000-00023, hdl.handle.net/1765/70217
Journal	Neurosurgery
Organisation	Department of Neurology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Vincent, A., Esandi, M. D., Avezaat, C., Vecht, C., Smitt, P. S., van Bekkum, D., … Bout, A. (1997). Preclinical testing of recombinant adenoviral herpes simplex virus- thymidine kinase gene therapy for central nervous system malignancies. Neurosurgery, 41(2), 442–452. doi:10.1097/00006123-199708000-00023

Publication